Bacteremia caused by Rothia mucilaginosa in a patient with Shwachman-Diamond syndrome [4]

Infection

Volumn 35, Issue 3, 2007, Pages 209-210

  Vaccher, S ^a   Cordiali, R ^a   Osimani, P ^a   Manso, E ^a   De Benedictis, F M ^a,b  

^a OSPEDALI RIUNITI   (Italy)

^b Salesi Children's Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NETILMICIN; SULTAMICILLIN;

ANTIBIOTIC THERAPY; BACTEREMIA; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; GRAM POSITIVE BACTERIUM; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; ROTHIA MUCILAGINOSA; SHWACHMAN SYNDROME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD, PRESCHOOL; EXOCRINE PANCREATIC INSUFFICIENCY; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MICROCOCCACEAE; OSTEOCHONDRODYSPLASIAS; RIFAMPIN; SYNDROME;

EID: 34250687010     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6284-8     Document Type: Letter

References (10)

1. Collins MD, Hutson RA, Baverud V, Falsen E: Characterization of a Rothia-like organism from a mouse: description of Rothia nasimurium sp. nov. and reclassification of Stomatococcus mucilaginosus as Rothia mucilaginosa comb. nov Int J Syst Evol Microbiol 2000; 50: 1247-1251.
2. Ascher D, Zbick C, White C: Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991; 13: 1048-1052.
3. Von Eiff C, Herrmann M, Peters G: Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995; 39: 268-270.
4. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically. Approved standard. NCCLS document. M7-A2. National Committee for Clinical Laboratory Standards, Villanova 1990.
5. Grinspan ZM, Pikora CA: Infections in patients with Shwachman-Diamond syndrome. Pediatr Infect Dis J 2005; 24: 179-181.
6. Dror Y, Freedman MH: Shwachman-Diamond syndrome. Br J Haematol 2002; 118: 701-713.
7. Fanourgiakis P, Georgala A, Vekemans M, Daneau D, Heymans C, Aoun M: Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of the cancer institute. Clin Microbiol Infect 2003; 9: 1068-1072.
8. Kaufhold A, Reinert RR, Kern W: Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature. Infection 1992; 20: 213-220.
9. Henwick S, Koehler M, Patrick CC: Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children. Clin Infect Dis 1993; 17: 667-671.
10. Skogen PG, Kolmannskog S, Bergh K: Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in neutropenic child. Clin Microbiol Infect 2001; 7: 39-41.